All these results revealed that LanCL1 expression level correlates with advanced tumor stage and poor prognosis in prostate cancer patients, suggesting that LanCL1 is likely involved in the tumorigenesis and progression of prostate cancer. This evidence concerns the gene LANCL1 and Familial prostate cancer.